Jessica E Hawley

11PUBLICATIONS
143CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 31, 2026
PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.

Alireza Ghodsi, Lukas Owens, Ridvan Arda Demirci

|Aug 06, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.

Hyun Jung Lee, Roman Gulati, Erolcan Sayar

|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Johann S de Bono, Anja Williams, Ignacio Melero

|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.

Lisa N Chesner, Fanny Polesso, Julie N Graff

|Apr 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study.

Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi

|Nov 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.

Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala

Pageof 2

Frequent Collaborators

4 joint publications

Petros Grivas

3 joint publications

Evan Y Yu

3 joint publications

Roman Gulati

2 joint publications

Charles G Drake